Bio-Rad cycle riders raise $73,055 during the Napa Valley Tour de Cure to benefit the ADA

Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostics products, helped raise approximately $1.1 million during the Napa Valley Tour de Cure, which took place on May 3 to benefit the American Diabetes Association.

As the Presenting Sponsor at this year's Napa Valley Tour de Cure, Bio-Rad's "friends and family" team of 146 riders was the largest of the 162 teams participating in the Napa Valley event. Bio-Rad riders raised $73,055, exceeding its total last year of $66,500, setting a new company record. The team was also named one of the Top 10 fundraising teams in the U.S. Bio-Rad also hosted teams in Long Beach, California, and Redmond, Washington. The Tour de Cure is a series of 80 cycling events that occur each year in different locations across the United States.

"Bio-Rad looks forward to Tour de Cure each year," said Bio-Rad President Norman Schwartz. "It is wonderful to see that we exceeded our fundraising goal this year. I'd like to recognize all of the event's participants, all over the U.S. By supporting events such as Tour de Cure, we are helping to improve the lives of those suffering from diabetes."